← Leaderboards
Patrick Donovan Quinn
University Of Texas At Austin
$2,229,178
Attributed
$2,373,314
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $565.2K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,373,314 · 5
By mechanism
R01$1,072,077 · 1
R00$743,680 · 1
K99$274,857 · 1
T32$216,204 · 1
F31$66,496 · 1
Top collaborators
- Andrea Grace Hohmann1 shared
- Kenneth P. Mackie1 shared
Most similar at University Of Texas At Austin
Same institution · by research overlap
- Cynthia A. Stappenbeck$3,837,254
- Sara Mernitz$156,500
- Leila Wehbe$1,265,617
- Matt Kammer-Kerwick$390,286
- Eleftherios Iakovou$78,236
Others in their field
Top investigators on “Literature”
- Jeffrey P Krischer · University Of South Florida$147,382,985
- Steven E Reis · University Of Pittsburgh At Pittsburgh$74,866,705
- Paul Warren Sternberg · California Institute Of Technology$60,378,437
- Leonardo Trasande · New York University School Of Medicine$53,162,280
- David Burch · Icf, Inc., Llc$51,878,712
- Alex Bateman · European Molecular Biology Laboratory$50,328,599
Research focus
LiteratureDesignSubstance Use DisorderRisk EstimatePrescription OpioidPoliciesPain ManagementJournalsPainPublished CommentIndividual PatientInternationalPersonsPharmacoepidemiologyLong-Term EffectsProgramsSocialDecision MakingMedicalComplementOpioid AnalgesicsOpioidAdverse EffectsTraining
Grant awards (11)
Assessing real-world evidence of the effects of opioid analgesic tapering on substance-related problems$349,045
R01 · FY2025 · DA · contact PI
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$216,204
T32 · FY2025 · DA
Assessing real-world evidence of the effects of opioid analgesic tapering on substance-related problems$349,045
R01 · FY2024 · DA · contact PI
Assessing real-world evidence of the effects of opioid analgesic tapering on substance-related problems$373,987
R01 · FY2023 · DA · contact PI
Pharmacoepidemiologic Studies of Prescription Opioid Analgesic Risks$248,409
R00 · FY2020 · DA · contact PI
Pharmacoepidemiologic Studies of Prescription Opioid Analgesic Risks$246,560
R00 · FY2019 · DA · contact PI
Pharmacoepidemiologic Studies of Prescription Opioid Analgesic Risks$248,711
R00 · FY2018 · DA · contact PI
Pharmacoepidemiologic Studies of Prescription Opioid Analgesic Risks$138,074
K99 · FY2017 · DA · contact PI
Pharmacoepidemiologic Studies of Prescription Opioid Analgesic Risks$136,783
K99 · FY2016 · DA · contact PI
Alcohol Response, Cognitive Impairment, and Alcohol-Related Negative Consequences$29,792
F31 · FY2013 · AA · contact PI
Alcohol Response, Cognitive Impairment, and Alcohol-Related Negative Consequences$36,704
F31 · FY2011 · AA · contact PI